[Effect of drug administration on the child with progressive muscular dystrophy].
D000293:Adolescent; D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D002648:Child; D002675:Child, Preschool; D003401:Creatine / Q000652:urine; D003402:Creatine Kinase / Q000097:blood; D003404:Creatinine / Q000652:urine; D004576:Electromyography; D004917:Erythromycin / Q000627:therapeutic use*; D005634:Fructose-Bisphosphate Aldolase / Q000097:blood; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000097:blood; D009136:Muscular Dystrophies / Q000188:drug therapy*; D009705:Nucleosides / Q000627:therapeutic use*; D013997:Time Factors; D014805:Vitamin B 12 / Q000627:therapeutic use*
D009705:Nucleosides; D004917:Erythromycin; D003404:Creatinine; D007770:L-Lactate Dehydrogenase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D003402:Creatine Kinase; D005634:Fructose-Bisphosphate Aldolase; D003401:Creatine; D014805:Vitamin B 12